Skip to content

Ayurvedic Chikitsa of Nasa Arsha with Nasya karma and Avaleha

Management Of Nasa Arsha [Nasal Polyp] With Chitrakadi Taila Nasya And Pippalyadi Rasayan Avaleha

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013583
Enrollment
30
Registered
2018-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients Suffering from Nasa Arsh(Nasal Polyp)

Interventions

Intervention1: Management of Nasa Arsha With Chitrakadi Taila Nasya: 15 Patients taken in Group A and will be treated with Chitrakadi Taila Nasya in following dose and duration Number of sitting-5sit

Sponsors

Govt Akhandanand ayurved college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical features of NasArsha Nasal polyp Patients having age of 18 TO 60 years Nasya Yogya

Exclusion criteria

Exclusion criteria: Nasya Ayogya Patients having age of BELOW 18 to ABOVE 60 years. Angiofibroma Bleeding Polyps Malignant Conditions of Nose T.B, HIV, Hepetitis etc. immunodeficiency conditions Chronic Obstructive Pulmonary Disease Granuloma Any other condition which require surgery or any general debilitating condition

Design outcomes

Primary

MeasureTime frame
All the signs and symptoms of Nasaarsha will be assigned score depending upone their severity to assess the effect of the drugs at the time of Before treatment and After treatmentTimepoint: 47Days

Secondary

MeasureTime frame
All the signs and symptoms of Nasaarsha will be assigned score depending upone their severity to assess the effect of the drugs at the time of Before treatment and After treatmentTimepoint: 47Days

Countries

India

Contacts

Public ContactSejal Mahendrabhai Chaudhari

Govt Akhandanand ayurved college

ashavarsha_tarak@yahoo.co.in9328083435

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026